Acute Lymphoblastic Leukemia: Risk Stratification
1 Vues
administrator
06/15/23
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.
Montre plus
Commentaires de Facebook
Aucun commentaire trouvé